Drugs / TVR
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01563328 | Mar → May 2012 | HIV infectious disease | ViiV Healthcare | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TVR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01563328 ↗ |
| Action | Inhibit | “Boceprevir (BCV) and Telaprevir (TVR) are protease inhibitors” NCT01563328 ↗ |